FDA Enforcement Class II Ongoing

The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses.

Recall: Z-1086-2024 · Reported February 21, 2024

Enforcement

Recall Number
Z-1086-2024
Event ID
93799
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Quidel Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 21, 2024
Initiation Date
January 3, 2024
Classification Date
February 14, 2024
Address
2285 Rutherford Rd, N/A, Carlsbad, CA, 92008-8815, United States

Description

The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses.

Reason

One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.

Code Info

UDI-DI: 30014613339229. Lot: 709083

Distribution

US Nationwide distribution in the states of FL, TN, IL, LA, NY, IN.

Quantity

312 Kits